Schmidt Carolin, Weißmüller Sabrina, Heinz Corina C
Department of Corporate Clinical Research and Development, Biotest AG, 63303 Dreieich, Germany.
Department of Preclinical Research, Biotest AG, 63303 Dreieich, Germany.
Biomedicines. 2023 Nov 10;11(11):3022. doi: 10.3390/biomedicines11113022.
Severe infections induce immune defense mechanisms and initial tissue damage, which produce an inflammatory neutrophil response. Upon dysregulation of these responses, inflammation, further tissue damage, and systemic spread of the pathogen may occur. Subsequent vascular inflammation and activation of coagulation processes may cause microvascular obstruction at sites distal to the primary site of infection. Low immunoglobulin (Ig) M and IgG levels have been detected in patients with severe infections like sCAP and sepsis, associated with increased severity and mortality. Based on Ig's modes of action, supplementation with polyvalent intravenous Ig preparations (standard IVIg or IgM/IgA-enriched Ig preparations) has long been discussed as a treatment option for severe infections. A prerequisite seems to be the timely administration of Ig preparations before excessive tissue damage has occurred and coagulopathy has developed. This review focuses on nonclinical and clinical studies that evaluated tissue-protective activities resulting from interactions of Igs with neutrophils, complement, and the coagulation system. The data indicate that coagulopathy, organ failure, and even death of patients can possibly be prevented by the timely combined interactions of (natural) IgM, IgA, and IgG with neutrophils and complement.
严重感染会引发免疫防御机制和初始组织损伤,进而产生炎症性中性粒细胞反应。一旦这些反应失调,可能会发生炎症、进一步的组织损伤以及病原体的全身扩散。随后的血管炎症和凝血过程激活可能导致感染原发部位远端的微血管阻塞。在患有严重社区获得性肺炎(sCAP)和脓毒症等严重感染的患者中,已检测到低免疫球蛋白(Ig)M和IgG水平,这与病情严重程度增加和死亡率升高有关。基于Ig的作用方式,长期以来一直讨论补充多价静脉注射Ig制剂(标准静脉注射免疫球蛋白或富含IgM/IgA的Ig制剂)作为严重感染的一种治疗选择。一个前提似乎是在发生过度组织损伤和凝血病之前及时给予Ig制剂。本综述重点关注评估Ig与中性粒细胞、补体和凝血系统相互作用所产生的组织保护活性的非临床和临床研究。数据表明,(天然)IgM、IgA和IgG与中性粒细胞和补体的及时联合相互作用可能预防患者的凝血病、器官衰竭甚至死亡。